Phenylurea derivatives

The present invention relates to a therapeutic or prophylactic agent for diseases associated with orexin receptors, particularly orexin type 2 receptors, containing a novel compound having a urea skeleton or a pharmaceutically acceptable salt thereof as an active ingredient. Specifically, the presen...

Full description

Saved in:
Bibliographic Details
Main Authors LEE JONG-KWANG, UESUGI JUNICHIRO, KOMIYA MASAFUMI, IDEUE, EIJI, TANAKA DAISUKE, FUNAKOSHI YUTA
Format Patent
LanguageChinese
English
Published 13.02.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a therapeutic or prophylactic agent for diseases associated with orexin receptors, particularly orexin type 2 receptors, containing a novel compound having a urea skeleton or a pharmaceutically acceptable salt thereof as an active ingredient. Specifically, the present invention relates to a therapeutic or prophylactic agent for diseases such as narcolepsy, idiopathic hypnosis, hypnosis, sleep apnea syndrome, and the like. 本发明涉及含有具有脲骨架的新型化合物或其制药学上可接受的盐作为有效成分的针对与食欲素受体、特别是与食欲素2型受体相关的疾病的治疗药或预防药。具体而言，涉及发作性睡病、特发性睡眠过度、睡眠过度、睡眠呼吸中止综合征等疾病的治疗药或预防药。
Bibliography:Application Number: CN202280037665